Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05227053 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

STOP AF First Post-Approval Study

StatusRecruiting
PhaseNot specified
Started2022-04-28
View on ClinicalTrials.gov ↗
The STOP AF First PAS is a prospective, global, multi-center, observational trial.

Amendment record

Amended 18 times since 2022-01-27; most recent filed 2026-07-20. Every amendment is listed below.

Dates here are the day the sponsor filed the amendment, not the day ClinicalTrials.gov published it. Version history last read from ClinicalTrials.gov on 2026-08-30.

2026-07-20
Amendment Study Status, Contacts/Locations v18
2026-05-19
Amendment Study Status, Contacts/Locations v17
2025-11-12
Amendment Study Status, Oversight, IPDSharing v16
2025-04-21
Amendment Study Status, Oversight, Contacts/Locations, IPDSharing v15
2025-02-11
Amendment Study Identification, Study Status, Sponsor/Collaborators v14
2024-12-11
Amendment Study Status, Eligibility v13
2024-08-27
Amendment Study Status, Contacts/Locations v12
2024-04-29
Amendment Study Status, Contacts/Locations v11
2024-01-26
Amendment Study Status, Contacts/Locations v10
2023-10-28
Amendment Study Status, Contacts/Locations v9
2023-07-24
Amendment Study Status, Contacts/Locations v8
2023-04-25
Amendment Study Status, Contacts/Locations v7
2023-02-13
Amendment Study Status v6
2023-01-18
Amendment Study Status, Contacts/Locations v5
2022-10-18
Amendment Not Yet RecruitingRecruiting Study Status, Contacts/Locations v4
2022-04-04
Amendment Study Status v3
2022-03-11
Amendment Study Status v2
2022-02-04
Amendment Study Status, Study Description, Conditions, Arms and Interventions, Outcome Measures, Eligibility, Contacts/Locations v1
2022-01-27
Original filing
Trial Details
NCT Number NCT05227053
Lead Sponsor Medtronic Cardiac Ablation Solutions
Conditions Paroxysmal Atrial Fibrillation
Enrollment 200 participants
Start Date 2022-04-28
Primary Completion 2028-04 (estimated)
Study Completion 2028-04 (estimated)
Updated on ClinicalTrials.gov 2026-07-22